A randomized placebo−controlled clinical trial of oral green tea epigallocatechin 3−gallate on erythropoiesis and oxidative stress in transfusion−dependent β−thalassemia patients

Kornvipa Settakorn, Sasinee Hantrakool, Touchwin Petiwathayakorn, Nuntouchaporn Hutachok, Adisak Tantiworawit, Pimlak Charoenkwan, Nopphadol Chalortham, Anchan Chompupoung, Narisara Paradee, Pimpisid Koonyosying, Somdet Srichairatanakool · 2024

Read A randomized placebo−controlled clinical trial of oral green tea epigallocatechin 3−gallate on erythropoiesis and oxidative stress in transfusion−dependent β−thalassemia patients by Kornvipa Settakorn, Sasinee Hantrakool, Touchwin Petiwathayakorn, Nuntouchaporn Hutachok, Adisak Tantiworawit, Pimlak Charoenkwan, Nopphadol Chalortham, Anchan Chompupoung, Narisara Paradee, Pimpisid Koonyosying, Somdet Srichairatanakool (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10848917.txt.

Description

Kornvipa Settakorn and co-authors report a trial, published in 2023, of a green tea compound in patients who need regular blood transfusions for beta-thalassemia. The compound, EGCG, is the main active part of green tea extract. It can soak up harmful free radicals, bind iron, and may protect red blood cell growth, which this disease disrupts.

Twenty-seven patients were split at random into a placebo group and two dose groups. They took the tablets once a day for sixty days, and blood tests tracked cell counts, chemistry, and stress markers. Hemoglobin rose more in the tea groups, and iron on red cell membranes tended to fall. The authors see the compound as a helpful add-on worth further study.

Catalog record

CREATORKornvipa Settakorn, Sasinee Hantrakool, Touchwin Petiwathayakorn, Nuntouchaporn Hutachok, Adisak Tantiworawit, Pimlak Charoenkwan, Nopphadol Chalortham, Anchan Chompupoung, Narisara Paradee, Pimpisid Koonyosying, Somdet Srichairatanakool
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10848917

Browse the full library · About the Tower of Babel